| Literature DB >> 27590053 |
Enrique Castro-Sánchez1, Luke S P Moore2,3, Fran Husson4, Alison H Holmes2,3.
Abstract
BACKGROUND: Antimicrobial resistance is driven by multiple factors. Resolving the threat to human and animal health presented by drug-resistant infections remains a societal challenge that demands close collaboration between scientists and citizens. We compared current public views about key contributing factors to antimicrobial resistance with those expressed by experts.Entities:
Keywords: Antimicrobial resistance; Health literacy; Public awareness
Mesh:
Substances:
Year: 2016 PMID: 27590053 PMCID: PMC5010725 DOI: 10.1186/s12879-016-1810-x
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Factors identified as driving global antimicrobial resistance
| Factors | Plain language translation |
|---|---|
| Human antimicrobial mis-/over-use | Misuse and/or overuse of antibiotics in humans (e.g. not finishing a course of antibiotics, taking antibiotics for viral, rather than bacterial, infections) |
| Animal antimicrobial mis-/over-use | Misuse and/or overuse of antibiotics in animals (e.g. farming) |
| Environmental contamination (including sewage and heavy metals) | Waste products from antibiotics entering the environment (through manufacture, sewage and disposal) |
| Healthcare transmission | Resistant bacteria being passed between people in hospital and other healthcare areas |
| Sub-optimal rapid diagnostics | A lack of quick, accurate tests to diagnose infections |
| Sub-optimal preventative medicine/vaccination | A lack of effective vaccines and poor uptake of existing ones |
| Sub-optimal dosing, including from substandard and falsified medications | Incorrect dosing of antibiotics in humans (e.g. not adjusting dosage for body weight) |
| Travel | Human travel from one area of the globe to another, spreading resistant bugs |
| Mass drug administration in human health | Mass drug administration – i.e. the regular giving of antibiotics to a large group of people (e.g. a whole state or country) to treat an infection, regardless of whether individuals are ill or not |
Responses by attendees to public engagement event
| Factors | n/N (%) |
|---|---|
| Human antimicrobial mis-/over-use | 192/405 (47 · 4 %) |
| Animal antimicrobial mis-/over-use | 66/405 (16 · 3 %) |
| Mass drug administration in human health | 57/405 (14 · 07 %) |
| Healthcare transmission | 36/405 (8 · 89 %) |
| Travel | 17/405 (4 · 2 %) |
| Sub-optimal dosing, including from substandard or falsified medications | 15/405 (3 · 7 %) |
| Environmental contamination (including sewage and heavy metals) | 11/405 (2 · 72 %) |
| Sub-optimal rapid diagnostics | 10/405 (2 · 47 %) |
| Sub-optimal preventative medicine/vaccination | 1/405 (0 · 25 %) |
Fig. 1Expert versus public opinion regarding the relative contribution of selected drivers of antimicrobial resistance. Numerical values in graph displaying public opinion results present Tablet 2 percentages normalised to 0–10. For comparison, X-axis and size of bubbles in graph displaying public opinion results use evidence parameters by Holmes, Moore et al. [11]